Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.
Thomson
Essential Science Indicators - Special Topics  RSS feeds for the editorial Web sites of Essential Science Indicators.
All Topics Menu
Help || About || Contact

  
|  Previous Page  |
  |  Special Topics Menu  |  |  Next Page  |
  

ESI Special Topic of:
"Angiogenesis," Published August 2004

•> Search Special Topics
Angiogenesis Menu

Angiogenesis

TOP JOURNALS

  Top 20 Overall
Total cites Number of papers • Cites per paper
|| Ranked by cites per paper ||
1994-2004 (second bimonthly)

Rank     Journal Total
Cites
Number
of Papers
Cites Per
Paper
1 NATURE MED 8178 71 115.18
2 J CLIN INVEST 4606 51 90.31
3 PROC NAT ACAD SCI USA 4759 72 66.1
4 AMER J PATHOL 5320 92 57.83
5 J NAT CANCER INST 2426 54 44.93
6 CANCER RES 8790 211 41.66
7 J BIOL CHEM 2021 61 33.13
8 CANCER 1250 40 31.25
9 BREAST CANCER RES TREAT 1011 36 28.08
10 CANCER METAST REV 639 27 23.67
11 ONCOGENE 965 42 22.98
12 LANCET 825 38 21.71
13 CIRC RES 930 43 21.63
14 INT J CANCER 1868 89 20.99
15 BIOCHEM BIOPHYS RES COMMUN 1222 71 17.21
16 J PATHOL 1055 63 16.75
17 BRIT J CANCER 1669 100 16.69
18 EUR J CANCER 1341 83 16.16
19 CLIN CANCER RES 2463 176 13.99
20
Top of page to menu
MICROVASCULAR RES 753 56 13.45

ESI Special Topic of:
"Angiogenesis," Published August 2004

•> Search Special Topics
Angiogenesis Menu || All Topics Menu

Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.